Price T Rowe Associates Inc ARRIVENT BIOPHARMA INC Transaction History
Price T Rowe Associates Inc
- $812 Billion
- Q1 2025
Number of Shares
12,471
Previous 10,965
13.73%
Holding current value
$231,000
Previous $293,000
21.16%
% of portfolio
0.0%
Previous 0.0%